Skip to main content
Erschienen in: Journal of Nephrology 4/2017

01.08.2017 | Original Article

Relationship between diurnal blood pressure and renal histopathological changes in white coat hypertension

verfasst von: Erhan Tatar, Adam Uslu, Funda Tasli, Murat Karatas

Erschienen in: Journal of Nephrology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Multiple epidemiological studies have clearly demonstrated the macrovascular risks associated with white coat hypertension (WCH) or sustained hypertension (SH). In patients with WCH, there is no literature available on renal histopathological changes and that on blood pressure pattern and native kidney outcome is scant. We aimed to clarify the relationship between blood pressure variables and pathological features of kidney biopsies in living kidney donors with WCH.

Methods

This cross-sectional study included living kidney donors with WCH (n = 10) and SH (n = 10), and 20 healthy kidney donors with similar demographic features (control group). Kidney allograft biopsy samples were obtained during transplantation and chronic glomerular, vascular and tubulointertitial changes were semiquantitatively scored according to the Banff classification.

Results

The mean age of the 20 hypertensive subjects (Group 1) and controls (Group 2) was 59.3 ± 8.5 versus 59.6 ± 7.6 years and almost half were female. There was no difference in renal function parameters between the groups; however, kidney histopathology in Group 1 was worse than Group 2 with a chronicity index of 2.80 ± 1.67 versus 1.75 ± 1.16 (p = 0.02). There was no difference between histopathological scores of patients with WCH or SH (chronicity index: 2.60 ± 1.43 vs. 2.70 ± 1.70, p = 0.88). Night-to-day mean arterial pressure (MAP) ratio was significantly associated with chronicity index in patients with WCH. Moreover, WCH patients with non-dipper hypertensive pattern had a worse chronicity index.

Conclusions

Significant histopathological alterations in the kidney were observed in patients with WCH and SH, and were accentuated in WCH patients with non-dipper blood pressure pattern.
Literatur
1.
Zurück zum Zitat Heidland A, Gerabek W, Sebekova K (2001) Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension. J Hum Hypertens 15:5–16CrossRefPubMed Heidland A, Gerabek W, Sebekova K (2001) Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension. J Hum Hypertens 15:5–16CrossRefPubMed
2.
Zurück zum Zitat Bauer JH, Reams GP, Wu Z (1991) The aging hypertensive kidney: pathophysiology and therapeutic options. Am J Med 90:21–27CrossRef Bauer JH, Reams GP, Wu Z (1991) The aging hypertensive kidney: pathophysiology and therapeutic options. Am J Med 90:21–27CrossRef
3.
Zurück zum Zitat Ritz E, Fliser D, Siebels M (1993) Pathophysiology of hypertensive renal damage. Am J Hypertens 6:241–244CrossRef Ritz E, Fliser D, Siebels M (1993) Pathophysiology of hypertensive renal damage. Am J Hypertens 6:241–244CrossRef
4.
5.
Zurück zum Zitat Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA (2013) Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens 22:1–9CrossRefPubMedPubMedCentral Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA (2013) Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens 22:1–9CrossRefPubMedPubMedCentral
6.
7.
Zurück zum Zitat Meyrier A (2015) Nephrosclerosis: update on a centenarian. Nephrol Dial Transplant 30:1833–1841CrossRefPubMed Meyrier A (2015) Nephrosclerosis: update on a centenarian. Nephrol Dial Transplant 30:1833–1841CrossRefPubMed
8.
Zurück zum Zitat Erten S, Gungor O, Sen S et al (2011) Nephrosclerosis and carotid atherosclerosis: lessons from kidney donor histology. Nephrology 16:720–724CrossRefPubMed Erten S, Gungor O, Sen S et al (2011) Nephrosclerosis and carotid atherosclerosis: lessons from kidney donor histology. Nephrology 16:720–724CrossRefPubMed
9.
Zurück zum Zitat Tatar E, Sen S, Harman M et al (2015) The relationship between renal volume and histology in obese and nonobese kidney donors. Eur J Clin Invest 45:565–571CrossRefPubMed Tatar E, Sen S, Harman M et al (2015) The relationship between renal volume and histology in obese and nonobese kidney donors. Eur J Clin Invest 45:565–571CrossRefPubMed
11.
Zurück zum Zitat SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103–2116CrossRef SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103–2116CrossRef
12.
Zurück zum Zitat Polónia JJ, Santos AR, Gama GM et al (1997) Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2–5 years). Blood Press Monit 2:289–295PubMed Polónia JJ, Santos AR, Gama GM et al (1997) Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2–5 years). Blood Press Monit 2:289–295PubMed
13.
Zurück zum Zitat Dolan E, Stanton A, Atkins N et al (2004) Determinants of white-coat hypertension. Blood Press Monit 9:307–309CrossRefPubMed Dolan E, Stanton A, Atkins N et al (2004) Determinants of white-coat hypertension. Blood Press Monit 9:307–309CrossRefPubMed
14.
Zurück zum Zitat Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D (2016) White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens 34:593–599CrossRefPubMed Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D (2016) White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens 34:593–599CrossRefPubMed
15.
Zurück zum Zitat Fagard RH, Thijs L, Staessen JA et al (2009) Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens 23:645–653CrossRefPubMed Fagard RH, Thijs L, Staessen JA et al (2009) Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens 23:645–653CrossRefPubMed
16.
Zurück zum Zitat Kimura G, Dohi Y, Fukuda M (2010) Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res 33:515–520CrossRefPubMed Kimura G, Dohi Y, Fukuda M (2010) Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res 33:515–520CrossRefPubMed
17.
Zurück zum Zitat Fukuda M, Munemura M, Usami T et al (2004) Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 65:621–625CrossRefPubMed Fukuda M, Munemura M, Usami T et al (2004) Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 65:621–625CrossRefPubMed
18.
Zurück zum Zitat Fukuda M, Mizuno M, Yamanaka T et al (2008) Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 52:1155–1160CrossRefPubMed Fukuda M, Mizuno M, Yamanaka T et al (2008) Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 52:1155–1160CrossRefPubMed
19.
Zurück zum Zitat Viazzi F, Cappadona F, Pontremoli R (2016) Microalbuminuria in primary hypertension: a guide to optimal patient management? J Nephrol 29(6):747–753CrossRefPubMed Viazzi F, Cappadona F, Pontremoli R (2016) Microalbuminuria in primary hypertension: a guide to optimal patient management? J Nephrol 29(6):747–753CrossRefPubMed
20.
Zurück zum Zitat Solez K, Axelsen RA, Benediktsson H et al (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411–422CrossRefPubMed Solez K, Axelsen RA, Benediktsson H et al (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411–422CrossRefPubMed
21.
Zurück zum Zitat Freedman BI, Cohen AH (2016) Hypertension-attributed nephropathy: what’s in a name? Nat Rev Nephrol 12:27–36CrossRefPubMed Freedman BI, Cohen AH (2016) Hypertension-attributed nephropathy: what’s in a name? Nat Rev Nephrol 12:27–36CrossRefPubMed
22.
Zurück zum Zitat Fine LG, Norman JT (2008) Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 74:867–872CrossRefPubMed Fine LG, Norman JT (2008) Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 74:867–872CrossRefPubMed
23.
Zurück zum Zitat Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Am Soc Nephrol 17:17–25CrossRef Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Am Soc Nephrol 17:17–25CrossRef
24.
Zurück zum Zitat Bidani AK, Griffin KA, Williamson G et al (2009) Protective importance of the myogenic response in the renal circulation. Hypertension 54:393–398CrossRefPubMedPubMedCentral Bidani AK, Griffin KA, Williamson G et al (2009) Protective importance of the myogenic response in the renal circulation. Hypertension 54:393–398CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Franklin SS, Thijs L, Hansen TW, O’Brien E, Staessen JA (2013) White-coat hypertension: new insights from recent studies. Hypertension 62(6):982–987CrossRefPubMed Franklin SS, Thijs L, Hansen TW, O’Brien E, Staessen JA (2013) White-coat hypertension: new insights from recent studies. Hypertension 62(6):982–987CrossRefPubMed
26.
Zurück zum Zitat Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M, Pauletto P (2008) Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 51(5):1300–1305CrossRefPubMed Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M, Pauletto P (2008) Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 51(5):1300–1305CrossRefPubMed
27.
Zurück zum Zitat Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, Kaplan N, Victor R, Vongpatanasin W (2015) Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the dallas heart study. J Am Coll Cardiol 66(20):2159–2169CrossRefPubMedPubMedCentral Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, Kaplan N, Victor R, Vongpatanasin W (2015) Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the dallas heart study. J Am Coll Cardiol 66(20):2159–2169CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Soma J, Dahl KJ, Widerøe TE (1999) White coat hypertension. Tidsskr Nor Laegeforen 119(5):667–670PubMed Soma J, Dahl KJ, Widerøe TE (1999) White coat hypertension. Tidsskr Nor Laegeforen 119(5):667–670PubMed
29.
Zurück zum Zitat Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig DI, Johnson RJ (2010) Uric acid and hypertension: cause or effect? Curr Rheumatol Rep 12(2):108–117CrossRefPubMed Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig DI, Johnson RJ (2010) Uric acid and hypertension: cause or effect? Curr Rheumatol Rep 12(2):108–117CrossRefPubMed
30.
Zurück zum Zitat Afsar B, Elsurer R, Ozdemir FN, Sezer S (2008) Uric acid and nocturnal nondipping in hypertensive patients with normal renal function. J Nephrol 21(3):406–411PubMed Afsar B, Elsurer R, Ozdemir FN, Sezer S (2008) Uric acid and nocturnal nondipping in hypertensive patients with normal renal function. J Nephrol 21(3):406–411PubMed
32.
Zurück zum Zitat Chou YC, Kuan JC, Yang T et al (2015) Elevated uric acid level as a significant predictor of chronic kidney disease: a cohort study with repeated measurements. J Nephrol 28(4):457–462CrossRefPubMed Chou YC, Kuan JC, Yang T et al (2015) Elevated uric acid level as a significant predictor of chronic kidney disease: a cohort study with repeated measurements. J Nephrol 28(4):457–462CrossRefPubMed
Metadaten
Titel
Relationship between diurnal blood pressure and renal histopathological changes in white coat hypertension
verfasst von
Erhan Tatar
Adam Uslu
Funda Tasli
Murat Karatas
Publikationsdatum
01.08.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 4/2017
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-017-0382-1

Weitere Artikel der Ausgabe 4/2017

Journal of Nephrology 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.